Skip to main content
Journal cover image

Patient Preferences in Treatment Choices for Early-Stage Lung Cancer.

Publication ,  Journal Article
Tong, BC; Wallace, S; Hartwig, MG; D'Amico, TA; Huber, JC
Published in: Ann Thorac Surg
December 2016

BACKGROUND: Decision-making for lung cancer treatment can be complex because it involves both provider recommendations based on the patient's clinical condition and patient preferences. This study describes the relative importance of several considerations in lung cancer treatment from the patient's perspective. METHODS: A conjoint preference experiment began by asking respondents to imagine that they had just been diagnosed with lung cancer. Respondents then chose among procedures that differed regarding treatment modalities, the potential for treatment-related complications, the likelihood of recurrence, provider case volume, and distance needed to travel for treatment. Conjoint analysis derived relative weights for these attributes. RESULTS: A total of 225 responses were analyzed. Respondents were most willing to accept minimally invasive operations for treatment of their hypothetical lung cancer, followed by stereotactic body radiation therapy (SBRT); they were least willing to accept thoracotomy. Treatment type and risk of recurrence were the most important attributes from the conjoint experiment (each with a relative weight of 0.23), followed by provider volume (relative weight of 0.21), risk of major complications (relative weight of 0.18), and distance needed to travel for treatment (relative weight of 0.15). Procedural and treatment preferences did not vary with demographics, self-reported health status, or familiarity with the procedures. CONCLUSIONS: Survey respondents preferred minimally invasive operations over SBRT or thoracotomy for treatment of early-stage non-small cell lung cancer. Treatment modality and risk of cancer recurrence were the most important factors associated with treatment preferences. Provider experience outweighed the potential need to travel for lung cancer treatment.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Ann Thorac Surg

DOI

EISSN

1552-6259

Publication Date

December 2016

Volume

102

Issue

6

Start / End Page

1837 / 1844

Location

Netherlands

Related Subject Headings

  • Risk
  • Respiratory System
  • Patient Preference
  • Patient Participation
  • Neoplasm Staging
  • Minimally Invasive Surgical Procedures
  • Middle Aged
  • Male
  • Lung Neoplasms
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tong, B. C., Wallace, S., Hartwig, M. G., D’Amico, T. A., & Huber, J. C. (2016). Patient Preferences in Treatment Choices for Early-Stage Lung Cancer. Ann Thorac Surg, 102(6), 1837–1844. https://doi.org/10.1016/j.athoracsur.2016.06.031
Tong, Betty C., Scott Wallace, Matthew G. Hartwig, Thomas A. D’Amico, and Joel C. Huber. “Patient Preferences in Treatment Choices for Early-Stage Lung Cancer.Ann Thorac Surg 102, no. 6 (December 2016): 1837–44. https://doi.org/10.1016/j.athoracsur.2016.06.031.
Tong BC, Wallace S, Hartwig MG, D’Amico TA, Huber JC. Patient Preferences in Treatment Choices for Early-Stage Lung Cancer. Ann Thorac Surg. 2016 Dec;102(6):1837–44.
Tong, Betty C., et al. “Patient Preferences in Treatment Choices for Early-Stage Lung Cancer.Ann Thorac Surg, vol. 102, no. 6, Dec. 2016, pp. 1837–44. Pubmed, doi:10.1016/j.athoracsur.2016.06.031.
Tong BC, Wallace S, Hartwig MG, D’Amico TA, Huber JC. Patient Preferences in Treatment Choices for Early-Stage Lung Cancer. Ann Thorac Surg. 2016 Dec;102(6):1837–1844.
Journal cover image

Published In

Ann Thorac Surg

DOI

EISSN

1552-6259

Publication Date

December 2016

Volume

102

Issue

6

Start / End Page

1837 / 1844

Location

Netherlands

Related Subject Headings

  • Risk
  • Respiratory System
  • Patient Preference
  • Patient Participation
  • Neoplasm Staging
  • Minimally Invasive Surgical Procedures
  • Middle Aged
  • Male
  • Lung Neoplasms
  • Humans